Breakfast Symposia IgNS: Beyond Primary: The Complexities of Secondary Immunodeficiencies
Tuesday |
4/21/2026 |
7:15 AM –
8:45 AM
| Room: Cottonwood 6-7
Breakfast Symposia IgNS: Beyond Primary: The Complexities of Secondary Immunodeficiencies
This session will review the etiology, prevalence, and clinical implications of secondary immunodeficiency, with emphasis on iatrogenic and therapy-related drivers. The session outlines screening windows, laboratory evaluation, and risk-stratification strategies to distinguish transient from persistent immune suppression and guide appropriate intervention. Learners gain practical frameworks for interdisciplinary decision-making, including when to consider antimicrobial prophylaxis or immunoglobulin replacement therapy to improve patient safety and outcomes.
Breakfast will be served from 7:15 – 7:45 AM
Symposium will start at 7:45 AM, offering 1 CE credit
Supported through an unrestricted educational grant by IgNS.
This session will review the etiology, prevalence, and clinical implications of secondary immunodeficiency, with emphasis on iatrogenic and therapy-related drivers. The session outlines screening windows, laboratory evaluation, and risk-stratification strategies to distinguish transient from persistent immune suppression and guide appropriate intervention. Learners gain practical frameworks for interdisciplinary decision-making, including when to consider antimicrobial prophylaxis or immunoglobulin replacement therapy to improve patient safety and outcomes.
Breakfast will be served from 7:15 - 7:45 AM
Symposium will start at 7:45 AM, offering 1 CE credit
Supported through an unrestricted educational grant by IgNS.
Supported By
Learning Objectives
Differentiate primary versus secondary immunodeficiency based on etiology, clinical presentation, and laboratory findings.
Identify common systemic, metabolic, and drug-induced causes of secondary hypogammaglobulinemia across specialties.
Apply appropriate screening, laboratory assessment, and vaccine-challenge strategies to evaluate immune function.
Integrate risk-stratification and interdisciplinary management approaches, including prophylaxis and immunoglobulin therapy, to optimize patient care.
Speaker(s)
Antoine Azar MD
Associate Professor of Clinical Medicine, Immunology
Johns Hopkins
.png)
